Key facts
- Cyclopure’s last known valuation is $70.2M (May 2025).
- It has raised $24.0M; the latest was Later Stage VC ($15.2M) in May 2025.
- Notable investors include US National Science Foundation, United States Department of War, Cornell University, Irwin Jacobs, National Institute of Environmental Health Sciences — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Cyclopure
- ·The full record, as it builds
Funding rounds
No funding rounds for Cyclopure are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cyclopure
Provider of water treatment services intended to keep drinking water safe and purified. The company's services remove hazardous contaminants from water and offer adsorption products, which capture and remove micropollutants and pesticides, enabling consumers to receive purified and safe drinking water.
- Sector
- Business Products and Services (B2B)
- HQ
- Evanston, IL, United States
- Founded
- 2016
- Employees
- 28
- Website
- cyclopure.com/
- Ownership
- Privately Held (backing)
Cyclopure doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cyclopure shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cyclopure in its N-PORT filings yet. We sweep new filings monthly.